Stock Market Journalist
Stock Market Journalist
Browsing tag
donanemab
FDA approves new Alzheimer’s treatment, donanemab from Eli Lilly
Read more
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab
Read more